Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

NCT00933231 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

281

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: tacrolimus
DRUG: tacrolimus
BIOLOGICAL: Simulect
DRUG: Cellcept
DRUG: Corticosteroids
DRUG: Ramipril
DRUG: Irbesartan

Sponsor

Astellas Pharma Inc

Collaborators

[object Object]